Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

Condition:   SmallpoxIntervention:   Biological: IMVAMUNE (MVA-BN)Sponsors:   Bavarian Nordic;   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials